Tatyana Lebenkova
Family · Panorama City, CANPI 1265711766
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 313 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,309, 3.3 times the $689 reported in 2021. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 313 payments — averaging $23.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- UCB, Inc.$953
- SK Life Science, Inc.$756
- Biogen$728
- Teva Pharmaceuticals USA, Inc.$538
- Lilly USA, LLC$473
- plus $3K from 29 others
What the payments were for
- Food & beverage$7,358100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $1,149 |
| UCB, Inc. | 37 | $953 |
| SK Life Science, Inc. | 41 | $756 |
| Biogen | 38 | $728 |
| Teva Pharmaceuticals USA, Inc. | 22 | $538 |
| Lilly USA, LLC | 24 | $473 |
| Novartis | 17 | $332 |
| Neurelis, Inc. | 8 | $278 |
| Lundbeck LLC | 9 | $245 |
| Otsuka America Pharmaceutical, Inc. | 9 | $244 |
| Pfizer | 11 | $224 |
| Amgen | 6 | $176 |
| Aucta Pharmaceuticals, Inc. | 8 | $162 |
| Eisai Inc. | 6 | $143 |
| Sanofi | 4 | $120 |
| Genentech USA, Inc. | 3 | $92 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $84 |
| Livanova USA, Inc. | 2 | $65 |
| Acadia Pharmaceuticals Inc | 3 | $63 |
| Scilex Pharmaceuticals Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $60 |
| Kyowa Kirin, Inc. | 2 | $51 |
| Arbor Pharmaceuticals, Inc. | 2 | $39 |
| Johnson & Johnson | 1 | $39 |
| EMD Serono, Inc. | 1 | $36 |
| Boston Scientific | 1 | $33 |
| Jazz Pharmaceuticals Inc. | 1 | $30 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| GE HealthCare | 1 | $27 |
| Argenx US, Inc. | 1 | $26 |
| Abbott | 1 | $23 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| AstraZeneca | 1 | $22 |
| Bristol Myers Squibb | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
How this compares
$7,358 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Other family in Panorama City
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.